Molecular Analysis of the Iduronate-2-sulfatase Gene in Thai Patients with Hunter Syndrome

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 2008 May 27

PMID 18500569

Citations 11

Authors

S Keeratichamroen

J R Ketudat Cairns

D Wattanasirichaigoon

P Wasant

L Ngiwsara

P Suwannarat

S Pangkanon

J Kuptanon

P Tanpaiboon

T Rujirawat

S Liammongkolkul

J Svasti

Affiliations

Soon will be listed here.

Abstract

Molecular defects in the gene encoding the enzyme iduronate-2-sulfatase (IDS) result in Hunter disease (mucopolysaccharidosis type II, MPS II). To determine the molecular basis of MPS II in Thailand, the IDS gene was analysed in 20 Thai patients with Hunter syndrome from 18 unrelated families. A total of 19 different mutations, including 9 missense mutations, 3 nonsense mutations, 3 splice site alterations, 1 deletion, 2 indels, and 1 rearrangement were identified, 8 of which were novel (p.R101C, p.D148V, p.G224A, p.K227E, p.E254X, p.W337X, c.440_442delinsTT and c.720_731delinsTTTCAGATGTTCTCCCCAG). Evaluation of the IDS activity of two hemizygous variants identified in the same patient, p.R101C and p.R468Q, by expression of IDS with the individual mutations in COS 7 cells indicated that only the p.R468Q mutation affected IDS protein activity. Two exonic mutations, c.257C>T (p.P86L) and c.418G>A, were found to activate multiple cryptic splice sites, resulting in aberrantly spliced transcripts. Thus, MPS II in Thailand is caused by a diverse set of defects affecting both IDS protein production and activity.

Citing Articles

Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan.

Hattori Y, Sawada T, Kido J, Sugawara K, Yoshida S, Matsumoto S Mol Genet Metab Rep. 2023; 37:101003.

PMID: 38053932 PMC: 10694771. DOI: 10.1016/j.ymgmr.2023.101003.

Newborn Screening Program for Mucopolysaccharidosis Type II and Long-Term Follow-Up of the Screen-Positive Subjects in Taiwan.

Lin H, Chang Y, Lee C, Tu Y, Lo Y, Hung P J Pers Med. 2022; 12(7).

PMID: 35887520 PMC: 9320252. DOI: 10.3390/jpm12071023.

Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Keegan N, Wilton S, Fletcher S Front Genet. 2022; 12:806946.

PMID: 35140743 PMC: 8819188. DOI: 10.3389/fgene.2021.806946.

Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the "Gold Standard" Criteria Required to Make a Confirmatory Diagnosis.

Chuang C, Lee C, Tu R, Lo Y, Sisca F, Chang Y Diagnostics (Basel). 2021; 11(9).

PMID: 34573925 PMC: 8465393. DOI: 10.3390/diagnostics11091583.

Identification and Functional Characterization of Gene Mutations Underlying Taiwanese Hunter Syndrome (Mucopolysaccharidosis Type II).

Lin H, Tu R, Chern S, Lo Y, Fran S, Wei F Int J Mol Sci. 2019; 21(1).

PMID: 31877959 PMC: 6982257. DOI: 10.3390/ijms21010114.

References

Dou W, Peng C, Zheng J, Gu X . [Detection of two novel mutations of iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II]. Yi Chuan. 2007; 29(1):37-40. DOI: 10.1360/yc-007-0037. View

Shapiro M, Senapathy P . RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 1987; 15(17):7155-74. PMC: 306199. DOI: 10.1093/nar/15.17.7155. View

Lissens W, Seneca S, Liebaers I . Molecular analysis in 23 Hunter disease families. J Inherit Metab Dis. 1997; 20(3):453-6. DOI: 10.1023/a:1005335624386. View

Sukegawa-Hayasaka K, Kato Z, Nakamura H, Tomatsu S, Fukao T, Kuwata K . Effect of Hunter disease (mucopolysaccharidosis type II) mutations on molecular phenotypes of iduronate-2-sulfatase: enzymatic activity, protein processing and structural analysis. J Inherit Metab Dis. 2006; 29(6):755-61. DOI: 10.1007/s10545-006-0440-7. View

Bondeson M, Dahl N, Malmgren H, Kleijer W, Tonnesen T, Carlberg B . Inversion of the IDS gene resulting from recombination with IDS-related sequences is a common cause of the Hunter syndrome. Hum Mol Genet. 1995; 4(4):615-21. DOI: 10.1093/hmg/4.4.615. View

Hopwood J, Bunge S, Morris C, Wilson P, Steglich C, Beck M . Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene. Hum Mutat. 1993; 2(6):435-42. DOI: 10.1002/humu.1380020603. View

Vafiadaki E, Cooper A, Heptinstall L, Hatton C, Thornley M, Wraith J . Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease). Arch Dis Child. 1999; 79(3):237-41. PMC: 1717680. DOI: 10.1136/adc.79.3.237. View

Rathmann M, Bunge S, Beck M, Kresse H, Tylki-Szymanska A, Gal A . Mucopolysaccharidosis type II (Hunter syndrome): mutation "hot spots" in the iduronate-2-sulfatase gene. Am J Hum Genet. 1996; 59(6):1202-9. PMC: 1914889. View

Sukegawa K, Tomatsu S, Tamai K, Ikeda M, Sasaki T, Masue M . Intermediate form of mucopolysaccharidosis type II (Hunter disease): a C1327 to T substitution in the iduronate sulfatase gene. Biochem Biophys Res Commun. 1992; 183(2):809-13. DOI: 10.1016/0006-291x(92)90555-y. View

10.

Whitley C, Anderson R, Aronovich E, Crotty P, Anyane-Yeboa K, Russo D . Caveat to genotype-phenotype correlation in mucopolysaccharidosis type II: discordant clinical severity of R468W and R468Q mutations of the iduronate-2-sulfatase gene. Hum Mutat. 1993; 2(3):235-7. DOI: 10.1002/humu.1380020313. View

11.

Millat G, Froissart R, Cudry S, Bonnet V, Maire I, Bozon D . COS cell expression studies of P86L, P86R, P480L and P480Q Hunter's disease-causing mutations. Biochim Biophys Acta. 1998; 1406(2):214-8. DOI: 10.1016/s0925-4439(97)00096-3. View

12.

Froissart R, Maire I, Millat G, Cudry S, Birot A, Bonnet V . Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients. Clin Genet. 1998; 53(5):362-8. DOI: 10.1111/j.1399-0004.1998.tb02746.x. View

13.

Alves S, Mangas M, Prata M, Ribeiro G, Lopes L, Ribeiro H . Molecular characterization of Portuguese patients with mucopolysaccharidosis type II shows evidence that the IDS gene is prone to splicing mutations. J Inherit Metab Dis. 2006; 29(6):743-54. DOI: 10.1007/s10545-006-0403-z. View

14.

Voznyi Y, Keulemans J, van Diggelen O . A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease). J Inherit Metab Dis. 2002; 24(6):675-80. DOI: 10.1023/a:1012763026526. View

15.

Bunge S, Steglich C, Beck M, ROSENKRANZ W, Schwinger E, Hopwood J . Mutation analysis of the iduronate-2-sulfatase gene in patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mol Genet. 1992; 1(5):335-9. DOI: 10.1093/hmg/1.5.335. View

16.

Timms K, Lu F, Shen Y, Pierson C, Muzny D, Gu Y . 130 kb of DNA sequence reveals two new genes and a regional duplication distal to the human iduronate-2-sulfate sulfatase locus. Genome Res. 1995; 5(1):71-8. DOI: 10.1101/gr.5.1.71. View

17.

Kim C, Hwang H, Song S, Paik K, Kwon E, Moon K . Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations. Hum Mutat. 2003; 21(4):449-50. DOI: 10.1002/humu.9128. View

18.

Filocamo M, Bonuccelli G, Corsolini F, Mazzotti R, Cusano R, Gatti R . Molecular analysis of 40 Italian patients with mucopolysaccharidosis type II: New mutations in the iduronate-2-sulfatase (IDS) gene. Hum Mutat. 2001; 18(2):164-5. DOI: 10.1002/humu.1169. View

19.

Rathmann M, Bunge S, Steglich C, Schwinger E, Gal A . Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28. Hum Genet. 1995; 95(1):34-8. DOI: 10.1007/BF00225070. View

20.

Popowska E, Rathmann M, Tylki-Szymanska A, Bunge S, Steglich C, Schwinger E . Mutations of the iduronate-2-sulfatase gene in 12 Polish patients with mucopolysaccharidosis type II (Hunter syndrome). Hum Mutat. 1995; 5(1):97-100. DOI: 10.1002/humu.1380050114. View